CYR-064

COMBINATION_PRODUCT2 trials

Sponsors

Cyrano Therapeutics, Inc., University of Nebraska

Conditions

AnosmiaHyposmia

Phase 1

Theophylline Nasal Spray for PD-Related Hyposmia and Anosmia

WithdrawnNCT06498687

University of NebraskaAnosmia, Hyposmia

Start: 2025-04-30End: 2026-07-31Updated: 2025-03-13

Phase 2

Study of CYR-064 Versus Placebo in Patients.

CompletedNCT06019000

Cyrano Therapeutics, Inc.Hyposmia

Start: 2023-09-26End: 2025-11-21Updated: 2026-08-31